GlassScriptPhysician profile
Mohammad K Choudhry
NPI 1215318282
$3,204.81
in general payments reported to CMS, 2019-2025
17 companies · $527 in 2025
The $527 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $279 · 2021: $471 · 2022: $30.81 · 2023: $695 · 2024: $728 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384 · Travel and Lodging: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.11 |
| Travel and Lodging | $566.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $837.04 | 2019-2025 | Epclusa, Vemlidy |
| Olympus Corporation of The Americas | $595.85 | 2023-2024 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $367.05 | 2019-2021 | |
| Cook Medical LLC | $306.21 | 2021-2025 | Hemospray, Fusion |
| Janssen Pharmaceuticals, INC | $241.85 | 2019-2021 | |
| Pfizer INC. | $240.39 | 2019-2020 | |
| Olympus America INC. | $138.71 | 2024 | Endoclot Phs, Olympus, Single Use Electrosurgical Knife Kd-655 |
| Lilly USA, LLC | $124.00 | 2025 | Omvoh |
| Csl Behring | $79.25 | 2022-2024 | Kcentra |
| Madrigal Pharmaceuticals | $64.68 | 2025 | Rezdiffra |
| Abbvie INC. | $51.16 | 2025 | |
| Braintree Laboratories, INC. | $35.54 | 2025 | Suflave, Sutab |
| Vivus LLC | $32.76 | 2025 | Qsymia, Pancreaze |
| Ardelyx, INC. | $32.59 | 2025 | Ibsrela |
| Janssen Biotech, INC. | $21.54 | 2025 | Tremfya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $18.56 | 2021 | |
| Aimmune Therapeutics, INC. | $17.63 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Choudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.